Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
392 INR | -4.61% | -7.28% | -3.29% |
04-30 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
04-15 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.29% | 1.19B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India's Telangana Facility Gets Accreditation from Japanese Regulator